Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Thalamic haemorrhage vs internal capsule-basal ganglia haemorrhage: clinical profile and predictors of in-hospital mortality

  • Adrià Arboix1Email author,
  • Raquel Rodríguez-Aguilar2,
  • Montserrat Oliveres1,
  • Emili Comes1,
  • Luis García-Eroles3 and
  • Joan Massons1
BMC Neurology20077:32

https://doi.org/10.1186/1471-2377-7-32

Received: 08 June 2007

Accepted: 05 October 2007

Published: 05 October 2007

Abstract

Background

There is a paucity of clinical studies focused specifically on intracerebral haemorrhages of subcortical topography, a subject matter of interest to clinicians involved in stroke management. This single centre, retrospective study was conducted with the following objectives: a) to describe the aetiological, clinical and prognostic characteristics of patients with thalamic haemorrhage as compared with that of patients with internal capsule-basal ganglia haemorrhage, and b) to identify predictors of in-hospital mortality in patients with thalamic haemorrhage.

Methods

Forty-seven patients with thalamic haemorrhage were included in the "Sagrat Cor Hospital of Barcelona Stroke Registry" during a period of 17 years. Data from stroke patients are entered in the stroke registry following a standardized protocol with 161 items regarding demographics, risk factors, clinical features, laboratory and neuroimaging data, complications and outcome. The region of the intracranial haemorrhage was identified on computerized tomographic (CT) scans and/or magnetic resonance imaging (MRI) of the brain.

Results

Thalamic haemorrhage accounted for 1.4% of all cases of stroke (n = 3420) and 13% of intracerebral haemorrhage (n = 364). Hypertension (53.2%), vascular malformations (6.4%), haematological conditions (4.3%) and anticoagulation (2.1%) were the main causes of thalamic haemorrhage. In-hospital mortality was 19% (n = 9). Sensory deficit, speech disturbances and lacunar syndrome were significantly associated with thalamic haemorrhage, whereas altered consciousness (odds ratio [OR] = 39.56), intraventricular involvement (OR = 24.74) and age (OR = 1.23), were independent predictors of in-hospital mortality.

Conclusion

One in 8 patients with acute intracerebral haemorrhage had a thalamic hematoma. Altered consciousness, intraventricular extension of the hematoma and advanced age were determinants of a poor early outcome.

Background

Most studies of primary intracerebral haemorrhages are focused on the global assessment of patients with haemorrhagic stroke independent of the different topography of lesions [1, 2]. It has recently been shown that the clinical spectrum, prognosis and early mortality of patients with primary intracerebral haemorrhage are reasonably dependent on the site of bleeding [3]. On the other hand, thalamic haemorrhages and basal ganglia-internal capsule haemorrhages are a group of supratentorial cerebral haemorrhages of subcortical topography, with clinical characteristics that are clearly different from those of the remaining cases of lobar or brainstem haemorrhages [1, 2]. However, the differential clinical profile between subcortical cerebral haemorrhages of isolated thalamic topography and haemorrhages involving the basal ganglia and the internal capsule is poorly defined. Moreover, predictors of in-hospital mortality in patients with isolated thalamic haemorrhage are not clearly established probably because in clinical series collected from hospital-based stroke registries, separate analysis of thalamic haemorrhage as an individual clinical entity is rarely performed.

This aim of this study was to describe the aetiological, clinical and prognostic characteristics of patients with thalamic haemorrhage as compared with that of patients with basal ganglia-internal capsule haemorrhage collected from a prospective hospital-based stroke registry. A second objective was to identify predictors of in-hospital mortality in patients with thalamic haemorrhage.

Methods

The database of the "Sagrat Cor Hospital of Barcelona Stroke Registry" with data of 3420 acute stroke patients was searched for those with a diagnosis of intracerebral haemorrhage who were admitted consecutively to the Department of Neurology of the Sagrat Cor Hospital (an acute-care 350-bed teaching hospital in the city of Barcelona) between January 1986 and December 2002. Details of this on-going hospital-based stroke registry have been reported in previous studies [4, 5]. Data from stroke patients are entered following a standardized protocol with 161 items regarding demographics, risk factors, clinical features, laboratory and neuroimaging data, complications and outcome. Subtypes of stroke were classified according to the Cerebrovascular Study Group of the Spanish Neurological Society [6], which is similar to the National Institute of Neurological Disorders and Stroke Classification [7]. Definitions of cerebrovascular risk factors have been used by our group in previous studies [35].

For the purpose of this study, primary intracerebral haemorrhages diagnosed in 364 patients were collected. The region of the intracranial haemorrhage was identified on computerized tomographic (CT) scans and/or magnetic resonance imaging (MRI) of the brain. The volume of haematomas was measured. Haematomas were divided into small and large using a diameter of 30 mm. Topographies included the thalamus in 47 patients, internal capsule and basal ganglia in 77, cerebral lobes in 140, cerebellum in 27, brainstem in 18, primary intraventricular haemorrhage in 11 and multiple topographic involvement (when more than one of the aforementioned topographies was affected by the haemorrhage and the size of the haematoma was > 30 mm) in 44. The objective of this clinical study was to assess differential features in aetiology, risk factors, clinical findings and early outcome between the cohorts of patients with thalamic haemorrhage (n = 47) and internal capsule-basal ganglia haemorrhage (n = 77). Prior to conducting the study, approval was obtained from the Ethical Committee of Clinical Research of the hospital.

All patients were admitted to the hospital within 48 hours of onset of symptoms. On admission, demographic characteristics; salient features of clinical and neurological examination and results of laboratory tests (blood cell count, biochemical profile, serum electrolytes, urinalysis); chest radiography; twelve-lead electrocardiography; and brain CT and/or MRI were recorded. Angio-MRI was obtained during hospitalisation in 17% of cases and arterial digital subtraction angiography was performed in 16% of patients with thalamic haemorrhage in whom we could not find any risk factor for haemorrhagic stroke. Other investigations included echocardiography in 10.6% of patients and lumbar puncture in 6.4%. Degree of clinical disability at discharge from the hospital was evaluated according to modified Rankin scale (mRS) [8], and causes of death according to the criteria of Silver et al. [9].

Statistical analysis

Demographic characteristics, risk factors, clinical events and outcome of patients with thalamic haemorrhage and those with internal capsule-basal ganglia haemorrhage were compared using the Student's t-test or the Mann-Whitney U test for continuous variables and the chi-square (χ2) test (with Yate's correction when necessary) for categorical variables. Variables were subjected to multivariate analysis with a logistic regression procedure and forward stepwise selection if P < 0.10 after univariate testing. The effect of variables on the presence of thalamic haemorrhage and fatal outcome was studied in two multiple regression models based on demographic, vascular risk factors, and clinical and neuroimaging variables, in which thalamic haemorrhage and in-hospital mortality were the dependent variables, respectively. Statistical significance was set at P < 0.05.

Results

Thalamic haemorrhage accounted for 1.4% of all cases of stroke (n = 3420) and 13% of intracerebral haemorrhage (n = 364). There were 27 men and 20 women with a mean (SD) age of 71.6 (10.9) years. The following vascular risk factors in a decreasing order of frequency were observed: history of hypertension (61.7%), diabetes mellitus (17%) and alcohol abuse (> 80 g/day) (12.8%). Sudden onset of neurological deficit was recorded in 74.5% of cases. Motor deficit occurred in 78.7% of cases, sensory deficit in 70.2%, altered consciousness in 31.9%, headache in 29.8%, nausea or vomiting in 27.7%, speech disturbances (dysarthria, aphasia) in 21.3% and oculomotor and visual disturbances in 21.3% (upward gaze palsy with miotic unreactive pupils, skew ocular deviation). Abnormal involuntary movements were present in only 2 patients. On the other hand, 4 patients had a lacunar syndrome (pure sensory stroke 3, sensorimotor stroke 1). The topography of thalamic lesion [10] was anterior in 6% of cases, posteromedial in 24%, posterolateral in 48%, dorsal in 2% and affected all thalamic vascular territories in 20%. Intraventricular involvement was present in 42.6% of patients.

Hypertension (53.2%), vascular anomaly (6.4%), haematological conditions (4.3%) and anticoagulation (2.1%) were the main causes of thalamic haemorrhage. The aetiology of thalamic bleeding was not identified in 34% of patients. One patient had surgical intervention (ventricular drainage). Median duration of hospital stay was 20 days (25th–75th percentile, 11–30 days). At the time of hospital discharge, 1 patient (2.1%) was symptom free (mRS grade 0). Of the remaining 37 patients, 11 had moderate disability (mRS grade 3), 15 moderately severe disability (mRS grade 4) and 11 severe disability (mRS grade 5). Significant altered memory function was present in 1 patient at hospital discharge. A total of 9 patients died (in-hospital mortality rate 19.1%). The median time of death was 11 days (25th–75th percentile, 6–13.5 days). Cumulative in-hospital mortality in relation to length of hospital stay showed that 33% of all deaths had occurred on day 7, 88.5% on day 14, and 100% on day 90. Causes of death included cerebral herniation in 4 patients, pneumonia in 2, sepsis in 2 and unknown cause in 1.

When the groups of patients with thalamic haemorrhage with favourable and unfavourable outcome were compared (Table 1), advanced age, altered consciousness, neurological complications and intraventricular extension of the haemorrhage were significantly more frequent in patients who died. In the multivariate analysis, advanced age, altered consciousness and intraventricular involvement were independent variables significantly associated with in-hospital death (Table 2).
Table 1

Results of univariate analysis in 47 patients with thalamic haemorrhage according to early outcome

Data

Alive (n = 38)

Dead (n = 9)

P value

Age, years, mean (SD)

69.5 (10.9)

80.2 (5.2)

0.002

Sex

   

   Male

24 (88.9)

3 (11.1)

0.106

   Female

14 (70)

6 (30)

0.371

Valvular heart disease

   

   Absent

38 (100)

8 (17.4)

0.191

   Present

0

1 (100)

 

Transient ischaemic attack

   

   Absent

38 (100)

8 (17.4)

0.191

   Present

0

1 (100)

 

Obesity

   

   Absent

36 (83.7)

7 (16.7)

0.160

   Present

2 (50)

1 (50)

 

Hyperlipidemia

   

   Absent

34 (85)

6 (15)

0.117

   Present

4 (57.1)

3 (42.9)

 

Nausea, vomiting

   

   Absent

29 (85.3)

5 (14.7)

0.198

   Present

9 (69.2)

4 (30.8)

 

Altered consciousness

   

   Absent

30 (93.8)

2 (6.3)

0.002

   Present

8 (53.3)

7 (46.7)

 

Sensory deficit

   

   Absent

9 (64.3)

5 (35.7)

0.074

   Present

29 (87.9)

4 (12.1)

 

Lacunar syndrome

   

   Absent

34 (79.1)

9 (20.9)

0.724

   Present

4 (100)

0

 

Intraventricular involvement

   

   Absent

26 (96.3)

1 (3.7)

0.003

   Present

12 (60)

8 (40.5)

 

Neurological complications

   

   Absent

36 (90)

4 (10)

0.001

   Present

2 (28.6)

5 (71.4)

 

Respiratory events

   

   Absent

33 (84.6)

6 (15.4)

0.167

   Present

5 (62.5)

3 (37.5)

 

Data are n (%) unless otherwise stated.

Table 2

Variables associated with in-hospital death in patients with thalamic haemorrhage

Variable

β

SE (β)

Odds ratio (95% CI)

p

Model based on demographics, vascular risk factors and clinical variables*

    

   Altered consciousness

3.223

1.120

25.10 (2.8–225.3)

0.004

   Age

0.160

0.069

1.17 (1.03–1.34)

0.020

Model based on demographics, vascular risk factors, clinical features and neuroimaging variables

    

   Altered consciousness

3.678

1.471

39.59 (2.51–707.37)

0.012

   Intraventricular involvement

3.209

1.600

24.74 (1.07–569.60)

0.045

   Age

0.210

0.103

1.23 (1.01–1.51)

0.042

*β = -15.114; SE (β) = 5.651; goodness-of-fit χ2 = 1.265; df = 7; P = 0.989; area under the ROC curve = 0.924; sensitivity 60%; specificity 71%; positive predictive value 56%; negative predictive value 74%; correct classification 66.9%.

β = -21.386; SE (β) = 9.304; goodness-of-fit χ2 = 1.604 ; df = 7 ; P = 0.978; area under the ROC curve = 0.949; sensitivity 78%; specificity 87%; positive predictive value 57%; negative predictive value 94%; correct classification 85.1%.

The characteristics of patients with thalamic haemorrhage in comparison with the cohort of 77 patients with internal capsule-basal ganglia haemorrhage are shown in Table 3. History of chronic liver disease, sensory symptoms, nausea and/or vomiting and ataxia was significantly more frequent in patients with thalamic haemorrhage, whereas speech disturbances (dysarthria, aphasia) and clinical presentation as a lacunar syndrome were significantly more common among patients with internal capsule-basal ganglia haemorrhage. In the multivariate analysis sensory deficit (odds ratio [OR] = 2.33, 95% confidence interval [CI] 1.10–4.84; P = 0.040), speech disturbances (OR = 0.34, 95% CI 0.16–0.86; P = 0.015) and lacunar syndrome (OR = 0.26, 95% CI 0.15–0.89; P = 0.026) were independent predictors of isolated thalamic haemorrhage.
Table 3

Differences between patients with thalamic haemorrhage and patients with internal capsule-basal ganglia haemorrhage

Data

Thalamic haemorrhage

Internal capsule-basal ganglia haemorrhage

P value

Total patients

47

77

 

Sex, male

27 (57.4)

50 (64.9)

0.259

Age, years, mean (SD)

71.6 (10.9)

72.2 (12.2)

0.661

Vascular risk factors

   

   Hypertension

29 (61.7)

57 (74)

0.107

   Diabetes mellitus

8 (17)

9 (11.7)

0.282

   Dyslipemia

7 (14.9)

10 (13)

0.481

   Atrial fibrillation

5 (10.6)

11 (14.3)

0.384

   Ischaemic heart disease

3 (6.4)

5 (6.5)

0.646

   Cigarette smoking (> 20/day)

3 (6.4)

8 (10.4)

0.339

   Chronic liver disease

5 (10.6)

0

0.007

Clinical findings

   

   Sudden onset (min)

35 (74.5)

48 (52.3)

0.115

   Limb weakness

37 (78.7)

67 (87)

0.167

   Sensory symptoms

33 (70.2)

38 (49.4)

0.018

   Altered consciousness

15 (31.9)

23 (29.9)

0.482

   Headache

14 (29.8)

18 (23.4)

0.279

   Nausea, vomiting

13 (27.7)

10 (13)

0.037

   Speech disturbances (dysarthria, aphasia)

10 (21.3)

34 (44.2)

0.008

   Ataxia

4 (8.5)

0

0.019

   Lacunar syndrome

4 (8.5)

18 (23.4)

0.036

Ventricular involvement

20 (42.6)

12 (15.6)

0.001

Outcome

   

   In-hospital mortality

9 (19.1)

13 (16.9)

0.464

   Respiratory complications

8 (17)

8 (10.4)

0.212

   Urinary complications

8 (17)

7 (9.1)

0.152

   Infectious complications

16 (34)

17 (22.1)

0.106

   Symptom-free at discharge

1 (2.1)

6 (7.8)

0.180

Data are n (%) unless otherwise stated.

Discussion

Data regarding the frequency of isolated thalamic haemorrhage in the different hospital-based stroke registries are scarce, the present results show that thalamic haematomas is a subgroup of haemorrhagic stroke that accounted for 1.4% of all cases of stroke and 13% of intracerebral haemorrhages. The prevalence of thalamic haemorrhage in different series of primary intracerebral haemorrhage vary widely from 6% in the series of Juvela et al. [11] to 15.7% in the series of Tatu et al. [12]. In a subsample of 390 with haemorrhagic stroke reported by Kumral et al. [13], thalamic haemorrhage was diagnosed in 100 patients (25.6%).

Results of the present study show that patients with thalamic haemorrhage and patients with internal capsule-basal ganglia haemorrhage presented different clinical profiles, with sensory disturbances being significantly more frequent and speech disorders and lacunar syndrome being significantly less frequent in patients with thalamic haematoma. Prominent sensory loss, either anaesthesia or hypaesthesia affecting face, limbs and trunk, generally for all sensory modalities was found in 70.2% of patients, which is consistent with classical reports showing the predominance of sensory deficit as a cardinal feature of thalamic haemorrhage especially when the ventroposterolateral nucleus is affected [1, 14, 15].

Speech disturbances are less frequent in patients with thalamic haemorrhage (21%) as compared with those with internal capsule-basal ganglia haemorrhage (44.2%). Dysarthria and different types of aphasia was explained in thalamic haemorrhage as a disruption of any circuit (arranged as frontal rostrocaudal/thalamic mediolaterally) leading to dysfunction [1, 2]. However, interruption of the corticolingual pathways in the internal capsule may explain the higher frequency of speech disturbances (mainly dysarthria) in internal capsule-basal ganglia haemorrhages [16, 17].

Clinical presentation of thalamic haemorrhage in the form of a lacunar syndrome is very rare, and was documented in only 4 patients (8.5%), 3 of whom presenting with a pure sensory stroke and 1 a sensorimotor syndrome. This finding is in accordance with a recent study of our group [18] and with data reported in the literature showing that pure sensory stroke is classically associated with a lacunar thalamic infarction [19].

Whereas none of the patients in the series of Kumral et al. [13] presented with pure sensorimotor stroke, a lacunar syndrome was observed in 23.4% of our patients with internal capsule-basal ganglia haemorrhage, mainly in the form of a pure motor stroke or sensorimotor stroke. These findings are consistent with the study of Weisberg and Wall (20) who reported pure motor hemiparesis in 7 out of 10 patients as well as with other reports indicating that a small haematoma of subcortical topography in the internal capsule but also in the basal ganglia may cause a lacunar syndrome [21].

Thalamic haemorrhage is a severe clinical condition with an in-hospital mortality rate, in the present study, of 19%, and only one patient (2.1%) was symptom-free at discharge. The mortality rate of thalamic haemorrhage was 12% after 6 ± 6 days after stroke and 17.3% within 6 months in the series of Mori et al. [22]. In the series of Chung et al. [23], the case fatality was 37% at the time of discharge. On the other hand, the mortality rate of thalamic haemorrhage is generally lower than that of brainstem haemorrhages or cerebral haemorrhages of multiple topographies, which show a very high in-hospital mortality rate usually greater than 40% [3]. The mortality rate in patients with thalamic haemorrhage, however, is higher than that of patient with capsular stroke [3, 16, 17]. Altered consciousness, intraventricular hemorrhage and advanced age were independent predictors of in-hospital mortality in patients with thalamic haematoma.

The initial level of consciousness was always found to be a predictor of mortality in the differents series [3, 1115]. Previous studies reported that initially comatose or stupurous patients had the poorest chance of survival [1, 2]. Intraventricular haemorrhage has been found to be a predictor of in-hospital mortality in some studies [13, 24, 25] but not in others [11, 22, 26] and one study has even suggested that intraventricular bleeding is associated with improved outcome in thalamic haemorrhage [27]. However, our results shows that stroke-related deaths occurred in 40.5% of intraventricular haemorrhage cases and agree with that of the Steinke et al. [25] who found that in-hospital mortality occurred in 52% of thalamic haematomas with ventricular extension and that intraventricular extension is an powerful independent predictor of mortality (Table 4). Death increased with age and agree with the study of Mori et al. [22]. In the study of Daverat el al. [28], age was the most important predictor of death and functional outcome after spontaneous intracerebral haemorrhage.
Table 4

Thalamic haemorrhage. Series reported in the literature

Author, year [reference]

Patients

Type of study

Frequency intracerebral haemorrhages (%)

Ventricular Extension (%)

Ventricular extension as predictor of in-hospital death

In-hospital mortality (%)

Walshe, 1977 [14]

18

Clinical series

 

66

  

Barraquer-Bordas, 1981 [15]

23

Clinical series

 

50

 

39

Kwak, 1983 [26]

29

Clinical series

  

No

 

Weisberg, 1986 [24]

50

Clinical series

 

38

Yes

38

Steinke, 1992 [25]

44

Stroke data bank

 

47.7

Yes

31.8

Kumral, 1995 [13]

100

Stroke data bank

25.6

57

Yes

25

Mori, 1995 [22]

104

Clinical series

 

44

No

17.3 (6 months)

Lampl, 1995 [27]*

52

Clinical series

 

63.5

No

36.6 (6 moths)

Chung, 1996 [23]

175

Clinical series

  

37

Shah, 2005 [30]

53

Clinical series

 

66.6

No

15.7

Present series, 2007

47

Hospital-based stroke registry

13

42.6

Yes

19.1

*11 patients with thalamo-capsular haemorrhages and 41 patients with isolated thalamic haemorrhages

Presence of dense blood clot in the third ventricle in a CT scan indicate a poor outcome

Early expansion of cerebral haematoma of any topography is an important determinant of in-hospital mortality [29, 30]. Recent studies have shown that ultra-early haemostatic therapy with recombinant activated factor VII (rFVIIa) within four hours after the onset of intracerebral hemorrhage limits the growth of the haematoma, reduces mortality, and improves functional outcomes [31]. These preliminary findings will probably determine a change in the management of patients with acute intracerebral haemorrhage, in which ultra-early haemostatic therapy, – similar to the efficacy of early thrombolytic therapy in cerebral infarction –, followed by careful monitorization in specialised stroke units could be of paramount importance in the care of patients with intracerebral haemorrhage [32].

Conclusion

Approximately one in every 8 patients with acute intracerebral haemorrhage had a thalamic haematoma. Patients with isolated thalamic haemorrhage show a differential clinical profile than patients with internal capsule-basal ganglia haemorrhage. Altered consciousness, intraventricular involvement and advanced age were independent predictors of in-hospital mortality.

Abbreviations

CI: 

Confidence interval.

CT: 

Computed tomography

MRI: 

Magnetic resonance imaging

OR: 

Odds ratio.

ROC: 

Receiver operating characteristics.

SE: 

Standard error.

Declarations

Acknowledgements

We thank Drs O. García-Trallero, M. López, C. Manzano, M. Miguel and E. Císcar for their contribution in the collection of data, C. Targa and M. Balcells for the care of many of the patients included in the study, and Dr Marta Pulido for editing the manuscript and editorial assistance. No funding was received for the study itself or for editorial assistance.

Authors’ Affiliations

(1)
Cerebrovascular Division, Department of Neurology, Hospital Universitari del Sagrat Cor, Universitat de Barcelona
(2)
Department of Internal Medicine, Hospital Universitari del Sagrat Cor, Universitat de Barcelona
(3)
Clinical Information Systems, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

References

  1. Kase CS, Mohr JP, Caplan LR: Intracerebral hemorrhage. Stroke. Pathophysiology, Diagnosis, and Management. Edited by: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PhA. 2004, Philadelphia: Churchill Livingstone, 327-376.Google Scholar
  2. Kase CS: Subcortical hemorrhages. Subcortical Stroke. Edited by: Donnan G, Norrving B, Bamford J, Bogousslavsky J. 2002, London, UK: Oxford University Press, 347-377. 2Google Scholar
  3. Arboix A, Comes E, García Eroles L, Massons J, Oliveres M, Balcells M, Targa C: Site of bleeding and early outcome in primary intracerebral hemorrhage. Acta Neurol Scand. 2002, 105: 282-288. 10.1034/j.1600-0404.2002.1o170.x.View ArticlePubMedGoogle Scholar
  4. Arboix A, Morcillo C, García-eroles L, Massons J, Oliveres M, targa C: Different vascular risk factor profiles in ischemic stroke subtypes. The Sagrat Cor Hospital of Barcelona Stroke Registry. Acta Neurol Scand. 2000, 102: 264-270. 10.1034/j.1600-0404.2000.102004264.x.View ArticlePubMedGoogle Scholar
  5. Arboix A, Massons J, García-eroles L, Oliveres M, Balcells M, Targa C: Migrainous cerebral infarction in the Sagrat-Cor Hospital of Barcelona Stroke Registry. Cephalalgia. 2003, 23: 389-394. 10.1046/j.1468-2982.2003.00534.x.View ArticlePubMedGoogle Scholar
  6. Arboix A, Alvarez-Sabín J, Soler L, for the Cerebrovascular Study Group of the Spanish Society of Neurology: Nomenclatura de las enfermedades vasculares cerebrales. Neurologia. 1998, 13 (Suppl 1): 1-10.Google Scholar
  7. Special Report from the National Institute of Neurological Disorders and Stroke: Classification of cerebrovascular diseases. III. Stroke. 1997, 28: 1590-1594.View ArticleGoogle Scholar
  8. Bamford JM, Sandercock PAG, Warlow CP, Slattery J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1989, 20: 828-View ArticlePubMedGoogle Scholar
  9. Silver FL, Norris JW, Lewis AJ, Hachinski VC: Early mortality following stroke: a prospective review. Stroke. 1984, 15: 492-496.View ArticlePubMedGoogle Scholar
  10. Schmahmann JD: Vascular syndromes of the thalamus. Stroke. 2003, 34: 2264-2278. 10.1161/01.STR.0000087786.38997.9E.View ArticlePubMedGoogle Scholar
  11. Juvela S: Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol. 1995, 52: 1193-1200.View ArticlePubMedGoogle Scholar
  12. Tatu L, Moulin Th, Mohamad RE, Vuillier F, Rumbach L, Czorny A: Primary intracerebral hemorrhages in the Besançon Stroke Registry. Initial clinical and CT findings, early course and 30-day outcome in 350 patients. Eur Neurol. 2000, 43: 209-214. 10.1159/000008177.View ArticlePubMedGoogle Scholar
  13. Kumral E, Kocaer T, Ertubey NO, Kumral K: Thalamic hemorrhage. A prospective study of 100 patients. Stroke. 1995, 26: 964-970.View ArticlePubMedGoogle Scholar
  14. Walshe TM, Davis KR, Fisher CM: Thalamic hemorrhage: a computed tomographic-clinical correlation. Neurology. 1977, 27: 217-222.View ArticlePubMedGoogle Scholar
  15. Barraquer-Bordas L, Illa I, Escartín A, Ruscalleda J, Martí-Vilalta JL: Thalamic hemorrhage. A study of 23 patients with diagnosis by computed tomography. Stroke. 1981, 12: 524-527.View ArticlePubMedGoogle Scholar
  16. Arboix A, Martínez-Rebollar M, Oliveres M, García-Eroles L, Massons J, Targa C: Acute isolated capsular stroke: a clinical study of 148 cases. Clin Neurol Neurosurg. 2005, 107: 88-94.PubMedGoogle Scholar
  17. Miyai I, Suzuki T, Kang J, Volpe BT: Functional outcome in patients with hemorrhagic stroke in putamen and thalamus compared with those with stroke restricted to the putamen or thalamus. Stroke. 2000, 31: 1365-1369.View ArticlePubMedGoogle Scholar
  18. Arboix A, García-Plata C, García-Eroles L, Massons J, Comes E, Oliveres M, Targa C: Clinical study of 99 patients with pure sensory stroke. J Neurol. 2005, 252: 156-162. 10.1007/s00415-005-0622-5.View ArticlePubMedGoogle Scholar
  19. Fisher CM: Lacunar infarcts. A review. Cerebrovasc Dis. 1991, 1: 311-320. 10.1159/000108861.View ArticleGoogle Scholar
  20. Weisberg LA, Wall M: Small capsular hemorrhages: clinical-computed correlations. Arch Neurol. 1984, 41: 1255-1257.View ArticlePubMedGoogle Scholar
  21. Milandre L, Donnet A, Graziani N, Grisoli F, Khalil R: Les syndromes lacunaires par hémorragie intracérébrale. Acta Neurol Belg. 1992, 92: 125-137.PubMedGoogle Scholar
  22. Mori S, Sadoshima S, Ibayashi S, Fujishima M: Impact of thalamic hematoma on six-month mortality and motor and cognitive outcome. Stroke. 1995, 26: 620-626.View ArticlePubMedGoogle Scholar
  23. Chung CS, Caplan LR, Han W, Pessin MS, Lee KH, Kim JM: Thalamic hemorrhage. Brain. 1996, 119: 1873-1886. 10.1093/brain/119.6.1873.View ArticlePubMedGoogle Scholar
  24. Weisberg LA: Thalamic hemorrhage: clinical-CT correlations. Neurology. 1986, 36: 1382-1386.View ArticlePubMedGoogle Scholar
  25. Steinke W, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, Price TR, Hier DB: Thalamic stroke. Presentation and prognosis of infarcts and hemorrhages. Arch Neurol. 1992, 49: 703-710.View ArticlePubMedGoogle Scholar
  26. Kwak R, Kadoya S, Suzuki T: Factors affecting the prognosis in thalamic hemorrhage. Stroke. 1983, 14: 493-500.View ArticlePubMedGoogle Scholar
  27. Lampl Y, Gilad R, Eshel Y, Sarova-Pinhas I: Neurological and functional outcome in patients with supratentorial hemorrhages. Stroke. 1995, 26: 2249-2253.View ArticlePubMedGoogle Scholar
  28. Daverat P, Castel JP, Dartigues JF, Orgogozo JM: Death and functional outcome after spontaneous intracerebral hemorrhage: a prospective study of 166 cases using multivariate analysis. Stroke. 1991, 22: 1-6.View ArticlePubMedGoogle Scholar
  29. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J: Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997, 28: 1-5.View ArticlePubMedGoogle Scholar
  30. Shah SD, Kalita J, Misra UK, Mandal SK, Srivastava M: Prognostic predictors of thalamic hemorrhage. J Clin Neurosci. 2005, 12: 559-561. 10.1016/j.jocn.2004.08.010.View ArticlePubMedGoogle Scholar
  31. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005, 352: 777-785. 10.1056/NEJMoa042991.View ArticlePubMedGoogle Scholar
  32. Dávalos A: New perspectives in cerebral hemorrhage: from surgery to conservative treatment. [Article in Spanish]. Med Clin (Barc). 2005, 124: 735-736. 10.1157/13075446.View ArticleGoogle Scholar
  33. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/7/32/prepub

Copyright

© Arboix et al; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement